2022 China reports 8.1% ceftriaxone-resistant Neisseria gonorrhoeae, tripled in 5 years.
A highly antibiotic-resistant strain of gonorrhea has tripled in China in just five years, warn Chinese researchers. Cases of drug-resistant gonorrhea are increasing globally, with China reporting a prevalence of ceftriaxone-resistant Neisseria gonorrhoeae at 8.1% in 2022. The first-line treatment for gonorrhea, ceftriaxone, has shown resistance in China, and experts warn that this could spread worldwide.
March 28, 2024
5 Articles